Identification of a novel mutation site in maturity‑onset diabetes of the young in a Chinese family by whole‑exome sequencing

Yu,Han; Liu,Jingjin; Li,Xiaofei; Miao,Fang; Yang,Yanlan

doi:10.3892/mmr.2019.10464

Identification of a novel mutation site in maturity‑onset diabetes of the young in a Chinese family by whole‑exome sequencing

Authors:
- Han Yu
- Jingjin Liu
- Xiaofei Li
- Fang Miao
- Yanlan Yang
View Affiliations

Affiliations: Endocrinology Department, Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi 030012, P.R. China
Published online on: July 3, 2019 https://doi.org/10.3892/mmr.2019.10464
Pages: 2373-2380
Copyright : © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to determine the mutant genes and mutation sites in a family with maturity‑onset diabetes of the young (MODY), in order to provide evidence for the diagnosis and treatment of clinical MODY. Based on the clinical characteristics of MODY, one family was selected from the Department of Endocrinology of Shanxi Provincial People's Hospital (Shanxi, China). The family comprised seven individuals, four of which were healthy (without MODY), and the whole exome of the individual with MODY, her father and her mother were sequenced. A suspected case (patient's uncle) and a healthy individual (patient's aunt) were sequenced for verification. The Q30 ratio was >90% in the family of three and the sequencing quality was good. The alignment rate was >95%, while the repeat sequence was <10%, with a mean sequencing depth of >120x, which is sufficient to identify mutations. According to Mutation Taster and LRT, it was predicted that the p.leu73Pro mutation of the pancreatic and duodenal homeobox 1 (PDX1) gene was deleterious. The mutation was verified by next‑generation sequencing as the pathogenic site in this family. In conclusion, a novel mutation site of MODY type 4 in the PDX1 gene was identified in a family with MODY, which may provide a basis for its clinical treatment. Whole‑exome sequencing appears to be of assistance in accurately diagnosing MODY.

View Figures

View References

1	Anık A, Çatlı G, Abacı A and Böber E: Maturity-onset diabetes of the young (MODY): An update. J Pediatr Endocrinol Metab. 28:251–263. 2015. View Article : Google Scholar : PubMed/NCBI
2	Kim SH: Maturity-onset diabetes of the young: What do clinicians need to know? Diabetes Metab J. 39:468–477. 2015. View Article : Google Scholar : PubMed/NCBI
3	Kleinberger JW and Pollin TI: Undiagnosed MODY: Time for action. Curr Diab Rep. 15:1102015. View Article : Google Scholar : PubMed/NCBI
4	Anık A, Çatlı G, Abacı A, Sarı E, Yeşilkaya E, Korkmaz HA, Demir K, Altıncık A, Tuhan HÜ, Kızıldağ S, et al: Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing. J Pediatr Endocrinol Metab. 28:1265–1271. 2015. View Article : Google Scholar : PubMed/NCBI
5	Kwak SH, Jung CH, Ahn CH, Park J, Chae J, Jung HS, Cho YM, Lee DH, Kim JI and Park KS: Clinical whole exome sequencing in early onset diabetes patients. Diabetes Res Clin Pract. 122:71–77. 2016. View Article : Google Scholar : PubMed/NCBI
6	Johansson S, Irgens H, Chudasama KK, Molnes J, Aerts J, Roque FS, Jonassen I, Levy S, Lima K, Knappskog PM, et al: Exome sequencing and genetic testing for MODY. PLoS One. 7:e380502012. View Article : Google Scholar : PubMed/NCBI
7	Bonnefond A, Philippe J, Durand E, Muller J, Saeed S, Arslan M, Martínez R, De Graeve F, Dhennin V, Rabearivelo I, et al: Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing. Diabetes Care. 37:460–467. 2014. View Article : Google Scholar : PubMed/NCBI
8	Gragnoli C, Stanojevic V, Gorini A, Von Preussenthal GM, Thomas MK and Habener JF: IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes. Metabolism. 54:983–988. 2005. View Article : Google Scholar : PubMed/NCBI
9	Weng J, Macfarlane WM, Lehto M, Gu HF, Shepherd LM, Ivarsson SA, Wibell L, Smith T and Groop LC: Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations. Diabetologia. 44:249–258. 2001. View Article : Google Scholar : PubMed/NCBI
10	Stoffers DA, Ferrer J, Clarke WL and Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet. 17:138–139. 1997. View Article : Google Scholar : PubMed/NCBI
11	Ağladıoğlu SY, Aycan Z, Çetinkaya S, Baş VN, Önder A, Peltek Kendirci HN, Doğan H and Ceylaner S: Maturity onset diabetes of youth (MODY) in Turkish children: Sequence analysis of 11 causative genes by next generation sequencing. J Pediatr Endocrinol Metab. 29:487–496. 2016. View Article : Google Scholar : PubMed/NCBI
12	Szopa M, Ludwig-Gałęzowska A, Radkowski P, Skupień J, Zapała B, Płatek T, Klupa T, Kieć-Wilk B, Borowiec M, Młynarski W, et al: Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young. Pol Arch Med Wewn. 125:845–851. 2015.PubMed/NCBI
13	Andrews S: FastQC: A quality control tool for high throughput sequence data. BibSonomy; 2010
14	Li H and Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25:1754–1760. 2009. View Article : Google Scholar : PubMed/NCBI
15	Faust GG and Hall IM: SAMBLASTER: Fast duplicate marking and structural variant read extraction. Bioinformatics. 30:2503–2505. 2014. View Article : Google Scholar : PubMed/NCBI
16	McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M and DePristo MA: The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20:1297–1303. 2010. View Article : Google Scholar : PubMed/NCBI
17	Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G and Durbin R; 1000 Genome Project Data Processing Subgroup, : The sequence alignment/map format and SAMtools. Bioinformatics. 25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
18	Garrison E and Marth G: Haplotype-based variant detection from short-read sequencing. arXiv preprint arXiv:1207.3907. 2012.
19	Rimmer A, Phan H, Mathieson I, Iqbal Z, Twigg SRF; WGS500 Consortium, ; Wilkie AOM, McVean G and Lunter G: Integrating mapping-, assembly-and haplotype-based approaches for calling variants in clinical sequencing applications. Nat Genet. 46:9122014. View Article : Google Scholar : PubMed/NCBI
20	Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L and Wilson RK: VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22:568–576. 2012. View Article : Google Scholar : PubMed/NCBI
21	Chapla A, Mruthyunjaya MD, Asha HS, Varghese D, Varshney M, Vasan SK, Venkatesan P, Nair V, Mathai S, Paul TV and Thomas N: Maturity onset diabetes of the young in India-a distinctive mutation pattern identified through targeted next-generation sequencing. Clin Endocrinol (Oxf). 82:533–542. 2015. View Article : Google Scholar : PubMed/NCBI
22	Dusatkova P, Fang M, Pruhova S, Gjesing AP, Cinek O, Hansen T, Pedersen OB, Xu X and Lebl J: Lessons from whole-exome sequencing in MODYX families. Diabetes Res Clin Pract. 104:e72–74. 2014. View Article : Google Scholar : PubMed/NCBI
23	Wang X, Sterr M, Burtscher I, Chen S, Hieronimus A, Machicao F, Staiger H, Häring HU, Lederer G and Meitinger T: Genome-wide analysis of PDX1 target genes in human pancreatic progenitors. Mol Metab. 9:57–68. 2018. View Article : Google Scholar : PubMed/NCBI
24	Fajans SS, Bell GI, Paz VP, Below JE, Cox NJ, Martin C, Thomas IH and Chen M: Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60. Transl Res. 156:7–14. 2010. View Article : Google Scholar : PubMed/NCBI
25	Winter WE and Silverstein JH: Molecular and genetic bases for maturity onset diabetes of youth. Curr Opin Pediatr. 12:388–393. 2000. View Article : Google Scholar : PubMed/NCBI
26	Guazzarotti L, Bartolotta E and Chiarelli F: Maturity-onset diabetes of the young (MODY): A new challenge for pediatric diabetologists. J Pediatr Endocrinol Metab. 12:487–497. 1999. View Article : Google Scholar : PubMed/NCBI
27	Froguel P and Velho G: Molecular genetics of maturity-onset diabetes of the young. Trends Endocrinol Metab. 10:142–146. 1999. View Article : Google Scholar : PubMed/NCBI